KREBS BIOCHEMICALS & INDUSTRIES
|
The Current P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES is 4.45.
Share Price | ₹74.0 | Sep 03,2025 |
Market Cap | ₹159.9 Cr | |
Sales-TTM | ₹35.9 Cr | TTM-Standalone Results |
Price/Sales | 4.45x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of KREBS BIOCHEMICALS & INDUSTRIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹159.9 Cr] as on Sep 03,2025
(/) Sales [ ₹35.9 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 4.45x ]
Thus, for KREBS BIOCHEMICALS & INDUSTRIES , the investors are currently willing to pay '4.45 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of KREBS BIOCHEMICALS & INDUSTRIES !
The chart below summarizes the trend in P/S Ratio of KREBS BIOCHEMICALS & INDUSTRIES over the last five years.
Historical PS (Price/Sales) ratio chart of KREBS BIOCHEMICALS & INDUSTRIES
PS Ratio Performance Analysis for KREBS BIOCHEMICALS & INDUSTRIES
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.56x.
- KREBS BIOCHEMICALS & INDUSTRIES 's operated at median p/e ratio of 3.25x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio peaked in Mar2022 at 5.18x.
- KREBS BIOCHEMICALS & INDUSTRIES 's p/e ratio hit its five-year low in Mar2023 of 2.33x.
How does KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
KREBS BIOCHEMICALS & INDUSTRIES | 35.9 | 4.45 | 159.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.05 | 378,999.0 |
DIVIS LABORATORIES LTD | 9,652.0 | 16.95 | 163,635.0 |
CIPLA LTD | 27,811.2 | 4.59 | 127,544.0 |
TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.31 | 122,050.0 |
DR REDDYS LABORATORIES LTD | 33,519.9 | 3.14 | 105,373.0 |
MANKIND PHARMA LTD | 12,956.2 | 8.15 | 105,650.0 |
ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.30 | 101,464.0 |
LUPIN LTD | 23,375.9 | 3.81 | 89,142.5 |
AUROBINDO PHARMA LTD | 32,024.8 | 1.88 | 60,115.9 |
ABBOTT INDIA LTD | 6,589.9 | 10.51 | 69,285.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs KREBS BIOCHEMICALS & INDUSTRIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 1.88x |
Max industry PS | 16.95x |
Median industry PS | 4.59x |
Average industry PS | 6.83x |
You may also like the below Video Courses